ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
RBC Core Bond Pool

RBC Core Bond Pool (RCOR)

20,55
0,00
(0,00%)
Fermé 25 Novembre 10:00PM
Données en temps réel

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
20,55
Prix Achat
20,55
Prix Vente
20,55
Volume échangé
-
0,00 Fourchette du Jour 0,00
19,85 Plage de 52 semaines 20,98
Clôture Veille
20,55
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
31 044
Volume financier
-
VWAP
-

RCOR Dernières nouvelles

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular...

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular...

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the treatment of heart conditions Significant unmet...

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

REN-001 IND submission planned for the second half of 2022 Data from pilot pig study showing successful cardiac transduction with REN-001 delivered via low-dose retrograde coronary sinus...

Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy

Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for...

Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research

REN-001 delivered locally via low-dose retrograde coronary sinus infusion demonstrated robust, diffuse cardiomyocyte transduction in a large animal heart Renovacor, Inc. (NYSE: RCOR), a...

Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update

REN-001 advancing toward IND submission in the second half of 2022 with the initiation of a Phase I/II clinical trial in BAG3-DCM expected thereafter Strengthened executive team with appointment...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.09-0.43604651162820.6420.6420.514515320.57877296CS
4-0.03-0.14577259475220.5820.6920.512446720.58344417CS
12-0.15-0.72463768115920.720.9820.463104420.69076946CS
260.412.0357497517420.1420.9820.042893620.52680865CS
520.522.5961058412420.0320.9819.852716120.42248337CS
1560.522.5961058412420.0320.9819.852716120.42248337CS
2600.522.5961058412420.0320.9819.852716120.42248337CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock